Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

Trial Profile

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 20 Aug 2018

At a glance

  • Drugs Sitafloxacin (Primary) ; Ertapenem
  • Indications Urinary tract infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Aug 2018 Planned End Date changed from 1 Dec 2018 to 1 Jan 2019.
    • 10 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Jan 2019.
    • 21 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top